NICE severity modifier: Not all QALYs are created equal

NICE severity modifier: Not all QALYs are created equal

The UK’s National Institute for Health and Care Excellence (NICE) has published an update to its methods and processes for health technology assessment. The update follows a year-long review and includes a number of significant changes to how innovative...
Validating patient diagnosis in real-world studies

Validating patient diagnosis in real-world studies

When is a patient a patient? Diagnosis “validation” is the part of the recruitment process for patient-/caregiver-reported studies where the eligibility of the prospective participant is verified. This usually includes confirmation that the patient does indeed have a...
Keeping it real #3 – Co-creating rare disease registries

Keeping it real #3 – Co-creating rare disease registries

Missed our webinar about co-creating rare disease registries? Watch it here!   On Monday 15th November, Vitaccess hosted the 3rd webinar in the “Keeping it real” series. Dr Mark Larkin, CEO and Founder of Vitaccess; Dr Catherine Bottomley, Director of...
Vitaccess at Virtual ISPOR Europe 2021

Vitaccess at Virtual ISPOR Europe 2021

ISPOR Europe 2021 is just around the corner and the Vitaccess team is looking forward to sharing insights with you during the event as well as our poster presentations. We will be part of the podium session “Two years of COVID-19: what has been the global impact on...
Skip to content